Integrin Receptor Antagonists

Integrin Receptor Antagonist

Colitis, Ulcerative

Crohn Disease

Enteritis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Vedolizumab, an integrin receptor antagonist, is a humanized IgG<span class="Sub">1 </span>monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.</p><div class="Section" data-sectioncode="42229-5"><a name="section-9.1"></a><p></p><p class="First"><span class="Italics Underline">Intravenous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion. After reconstitution with 4.8 mL Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP, the resulting concentration is 60 mg/mL with a deliverable volume of 5 mL (300 mg) and the resulting pH is approximately 6.3.</p><p>Each single-dose vial contains 300 mg vedolizumab, arginine hydrochloride (131.7 mg), histidine (23 mg), histidine monohydrochloride (21.4 mg), polysorbate 80 (3 mg), and sucrose (500 mg).</p></div><div class="Section" data-sectioncode="42229-5"><a name="section-9.2"></a><p></p><p class="First"><span class="Italics Underline">Subcutaneous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) injection is supplied as a sterile, clear to moderately opalescent, colorless to slightly yellow, preservative-free solution for subcutaneous administration.</p><p>Each single-dose prefilled syringe or single-dose prefilled pen (ENTYVIO PEN) contains 108 mg vedolizumab, arginine hydrochloride (17.77 mg), citric acid monohydrate (0.18 mg), histidine (3.86 mg), histidine monohydrochloride (1.86 mg), polysorbate 80 (1.35 mg), sodium citrate dihydrate (4.71 mg) and Sterile Water for Injection, USP, at a pH of 6.5.</p></div></section>

Entyvio

vedolizumab

vedolizumab 300 MG Injection

vedolizumab 300 MG Injection [Entyvio]

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]

0.68 ML vedolizumab 159 MG/ML Auto-Injector

0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]

Tufts Medical Center Specialty Pharmacy

Actemra

Alecensa

Alunbrig

Bosulif

Braftovi

Brukinsa

Cabometyx

Calquence

Cometriq

Cosentyx

Cotellic

Daurismo

Erivedge

Gavreto

Gilotrif

Herceptin

Ibrance

Iclusig

Idhifa

Imbruvica

Inlyta

Inqovi

Inrebic

Koselugo

Lenvima

Lonsurf

Lumakras

Lynparza

Matulane

Mekinist

Mektovi

Nerlynx

Nexavar

Odomzo

Olumiant

Orgovyx

Piqray

Qinlock

Retevmo

Rituxan

Rozlytrek

Rubraca

Stivarga

Tabrecta

Tafinlar

Tagrisso

Talzenna

Tasigna

Tazverik

Tibsovo

Truseltiq

Venclexta

Verzenio

Vitravki

Vizimpro

Votrient

Xalkori

Xospata

Xpovio

Xtandi

Zejula

Zelboraf

Zydelig

Zykadia

Entyvio | Tufts Medical Center Specialty Pharmacy

Which health plans does Tufts Medical Center Specialty Pharmacy have contracts with?

Does Tufts Medical Center Specialty Pharmacy work closely with Entyvio and Takeda Pharmaceuticals America, Inc.?

Does Tufts Medical Center Specialty Pharmacy offer services for Entyvio patients?

What conditions does Tufts Medical Center Specialty Pharmacy support?

How does Tufts Medical Center Specialty Pharmacy help with insurance?